Differences in sensitivity of children and adults to chemical toxicity: the NAS panel report

J V Bruckner1

  • 1Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, Georgia 30602-2352, USA.

Insights

Infants and children

Area of Science:

  • Environmental Health
  • Toxicology
  • Pediatrics

Background:

  • The National Academy of Sciences (NAS) Committee on Pesticides in the Diets of Infants and Children evaluated risks associated with pesticide exposure in young populations.
  • Understanding age-dependent toxicity is crucial for protecting vulnerable groups from chemical harm.

Purpose of the Study:

  • To assess the extent and health consequences of pesticide exposure in infants and children.
  • To provide recommendations for protecting children from the toxic effects of pesticides.

Main Methods:

  • Reviewed rodent mortality studies to contrast chemical toxicity in young versus adult subjects.
  • Analyzed age-related anatomical, biochemical, and physiological changes affecting chemical pharmacokinetics and pharmacodynamics.
  • Explored the utility of physiologically based pharmacokinetic (PBPK) models for predicting chemical behavior in children.

Main Results:

  • Age-dependent differences in chemical lethality were generally less than one order of magnitude.
  • Toxicity is compound- and age-dependent, with immature subjects sometimes exhibiting different responses.
  • Maturing organ systems in children may present unique windows of vulnerability to specific chemicals.

Conclusions:

  • Immaturity does not automatically equate to greater chemical sensitivity; toxicity is chemical-specific.
  • Physiologically based pharmacokinetic (PBPK) models can predict chemical exposure risks in children.
  • The existing 10-fold interspecies uncertainty factor is considered adequate for protecting infants and children.

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...